Hepatocellular carcinoma
Conditions
Interventions
Observation group:None
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with hepatocellular carcinoma who underwent radical (R0) surgical resection and were pathologically confirmed; 2.Patients had relatively complete clinicopathological data and more than 2 years follow-up information (including but not limited to treatment, survival and prognosis information); 3.Patients have not received any systemic therapy and/or local anti-tumor therapy before surgery, including but not limited to neoadjuvant or other forms of therapy.
Exclusion criteria
Exclusion criteria: 1.Patients were pregnant or lactating women; 2.Patients combined with other malignant tumors; 3.Patients received any other anti-tumor therapy before surgery, such as neoadjuvant therapy; 4.Patients who died within 2 years after surgery from causes other than tumor recurrence; 5.The sample of the patients was not qualified for quality control by protein extraction or the follow-up information of the patient was missing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early recurrence (tumor recurrence detected 2 years after surgery);Late recurrence or no recurrence (recurrence or no recurrence 2 years after surgery); | — |
Countries
China
Contacts
Public ContactHongcheng Sun
Shanghai General Hospital
Outcome results
None listed